data

KuCoin’s Liquidity Resilience and Sustained Growth Highlighted in CoinDesk Data 2025 Market Deep-Dive Report

PROVIDENCIALES, Turks and Caicos Islands, Dec. 22, 2025 /PRNewswire/ -- CoinDesk Data released its 2025 Market Deep-Dive Report, a comprehensive…

1 month ago

The 3D-Flow Architecture Breakthrough: A Universal, Scalable Digital Processor for Real-Time Pattern Recognition in High-Rate Data Streams A Platform to Save Millions of Lives and Billions of Euros

DALLAS, Dec. 20, 2025 (GLOBE NEWSWIRE) -- In PDF https://bit.ly/437YX7H) The Crosetto Foundation for the Reduction of Cancer Deaths, a…

1 month ago

Neuraxpharm Goes Live with TraceLink MINT to Standardize RealTime Data Exchange Across Its Global Supply Chain Network

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestrationBOSTON, Dec. 18, 2025 /PRNewswire/…

1 month ago

Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2025 – Genmab…

1 month ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

2 months ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

2 months ago

IBM to Acquire Confluent to Create Smart Data Platform for Enterprise Generative AI

$11B acquisition to deliver end-to-end data platform for businesses to connect, process and govern data for applications and AI agents…

2 months ago

NYSE Content Advisory: Pre-Market Update + ICE Data Show Home Affordability at Nearly Three-Year High

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

2 months ago

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

2 months ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

December 07, 2025 16:00 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…

2 months ago